Dear ESPT Members,
We are starting the fifth year of ESPT after a stimulating 2014 year:
A successful ESPT summer school in Rome (June 9-14): "Pharmacogenomics and Other Omics Leading to Personalized Medicine: Established and Emerging Scientific, Clinical and Ethical Aspects"
A very well attended conference in Santorini (September 25-27): 7th Santorini Conference Biologie Prospective "Systems Medicine, Personalized Health and Therapy"
More than these two events, the General Assembly has accepted the new strategy on:
National Societies linked to ESPT: 8 are now members and we are in contact with 14 others
Scientific groups: 12 will represented now the heart of our society and some more are ready to join. You will find the description of all of them on the web site: http://www.esptnet.eu/S1090/National+Societies+And+Scientific+Groups
We have also now 22 Corporate members and 23 liaisons with other European and International organizations.
Globally we are now more than 800 members!
In 2015, we will continue our development but at a more reasonable speed for consolidating our structure. Our main task will be to create and organize committee’s activities for preparing useful recommendations for our members, the clinicians and the patients.
In 2015, we will largely participate to Euromedlab with two symposia: “Systems Pharmacogenomics” and “IFCC TF-Pharmacogenetics” in Paris on June 24 and perhaps to the 12th Congress of EACPT (European Association for Clinical Pharmacology and Therapeutics) in Madrid June 27-30.
We will also have our 3rd ESPT Conference: “Integration of Pharmacogenomics in clinical decision support” in Budapest (October 7-9 - www.esptcongress.eu).
We hope to see you there!!
The European Society of Pharmacogenomics and Theranostics is a non-profit organization. Its aims are to promote education and research in pharmacogenomics and theranotics, to ensure high standards in their application to clinical practice and to facilitate contacts between all persons who share these aims, particularly those working in Europe. The Society will encourage and seek to integrate basic multidisciplinary research approaches and their translation into clinical benefits, and professional and public education in all areas of human pharmacogenetics, clinical pharmacology and laboratory medicine.